nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—CYP3A4—Pilocarpine—glaucoma	0.0353	0.236	CbGbCtD
Olopatadine—CYP3A4—Brinzolamide—glaucoma	0.0277	0.185	CbGbCtD
Olopatadine—CYP3A4—Dorzolamide—glaucoma	0.0268	0.178	CbGbCtD
Olopatadine—CYP3A4—Methazolamide—glaucoma	0.0239	0.159	CbGbCtD
Olopatadine—CYP3A4—Acetazolamide—glaucoma	0.0191	0.127	CbGbCtD
Olopatadine—CYP3A4—Clonidine—glaucoma	0.0173	0.115	CbGbCtD
Olopatadine—S100A2—Direct p53 effectors—POU4F2—glaucoma	0.0125	0.122	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—POU4F1—glaucoma	0.00682	0.0666	CbGpPWpGaD
Olopatadine—S100A12—ZBP1(DAI) mediated induction of type I IFNs—TBK1—glaucoma	0.00663	0.0648	CbGpPWpGaD
Olopatadine—S100B—ZBP1(DAI) mediated induction of type I IFNs—TBK1—glaucoma	0.00627	0.0613	CbGpPWpGaD
Olopatadine—S100A1—connective tissue—glaucoma	0.00558	0.149	CbGeAlD
Olopatadine—S100A13—eye—glaucoma	0.00513	0.138	CbGeAlD
Olopatadine—S100B—eye—glaucoma	0.005	0.134	CbGeAlD
Olopatadine—S100B—retina—glaucoma	0.00495	0.133	CbGeAlD
Olopatadine—S100A13—connective tissue—glaucoma	0.00495	0.133	CbGeAlD
Olopatadine—S100A12—connective tissue—glaucoma	0.00488	0.131	CbGeAlD
Olopatadine—S100B—connective tissue—glaucoma	0.00482	0.129	CbGeAlD
Olopatadine—S100A2—Validated transcriptional targets of TAp63 isoforms—FAS—glaucoma	0.00372	0.0363	CbGpPWpGaD
Olopatadine—S100A13—Tizanidine—Brimonidine—glaucoma	0.00364	0.309	CbGdCrCtD
Olopatadine—S100A2—p73 transcription factor network—NTRK1—glaucoma	0.0035	0.0342	CbGpPWpGaD
Olopatadine—S100A13—Tizanidine—Apraclonidine—glaucoma	0.00325	0.275	CbGdCrCtD
Olopatadine—S100A12—Cytosolic sensors of pathogen-associated DNA—TBK1—glaucoma	0.00315	0.0308	CbGpPWpGaD
Olopatadine—S100B—Cytosolic sensors of pathogen-associated DNA—TBK1—glaucoma	0.00298	0.0291	CbGpPWpGaD
Olopatadine—S100A2—p73 transcription factor network—FAS—glaucoma	0.00274	0.0268	CbGpPWpGaD
Olopatadine—S100A12—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—TBK1—glaucoma	0.0027	0.0264	CbGpPWpGaD
Olopatadine—S100B—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—TBK1—glaucoma	0.00255	0.0249	CbGpPWpGaD
Olopatadine—S100A2—Validated transcriptional targets of TAp63 isoforms—CDKN2A—glaucoma	0.0025	0.0244	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—TBK1—glaucoma	0.00228	0.0222	CbGpPWpGaD
Olopatadine—S100A13—Tizanidine—Clonidine—glaucoma	0.00225	0.191	CbGdCrCtD
Olopatadine—S100B—MyD88-independent cascade—TBK1—glaucoma	0.00215	0.021	CbGpPWpGaD
Olopatadine—Amitriptyline—NTRK2—glaucoma	0.0021	0.618	CrCbGaD
Olopatadine—S100A12—Activated TLR4 signalling—TBK1—glaucoma	0.00205	0.02	CbGpPWpGaD
Olopatadine—S100B—Activated TLR4 signalling—TBK1—glaucoma	0.00194	0.0189	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—TBK1—glaucoma	0.00193	0.0188	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—TBK1—glaucoma	0.00182	0.0178	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—FAS—glaucoma	0.00173	0.0169	CbGpPWpGaD
Olopatadine—S100A12—Toll-Like Receptors Cascades—TBK1—glaucoma	0.00171	0.0168	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—BCL2L1—glaucoma	0.00164	0.016	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—TBK1—glaucoma	0.00162	0.0158	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—CAV1—glaucoma	0.00158	0.0154	CbGpPWpGaD
Olopatadine—Amitriptyline—NTRK1—glaucoma	0.0013	0.382	CrCbGaD
Olopatadine—S100A2—Direct p53 effectors—MMP2—glaucoma	0.00127	0.0124	CbGpPWpGaD
Olopatadine—S100A13—Hydrochlorothiazide—Diclofenamide—glaucoma	0.00126	0.107	CbGdCrCtD
Olopatadine—HRH1—eye—glaucoma	0.00103	0.0275	CbGeAlD
Olopatadine—HRH1—connective tissue—glaucoma	0.000988	0.0265	CbGeAlD
Olopatadine—S100A13—Alprenolol—Metipranolol—glaucoma	0.000827	0.07	CbGdCrCtD
Olopatadine—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000792	0.00773	CbGpPWpGaD
Olopatadine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000774	0.00756	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—TP53—glaucoma	0.000649	0.00634	CbGpPWpGaD
Olopatadine—S100A13—Alprenolol—Betaxolol—glaucoma	0.000578	0.049	CbGdCrCtD
Olopatadine—S100A12—Innate Immune System—TXNIP—glaucoma	0.000566	0.00553	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—TBK1—glaucoma	0.000556	0.00543	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—TXNIP—glaucoma	0.000536	0.00523	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—TBK1—glaucoma	0.000525	0.00513	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—C1QB—glaucoma	0.000502	0.00491	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—OPN4—glaucoma	0.000486	0.00475	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—C1QB—glaucoma	0.000475	0.00464	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—BAD—glaucoma	0.000466	0.00455	CbGpPWpGaD
Olopatadine—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000455	0.00444	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—TXN—glaucoma	0.000448	0.00437	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—PTGFR—glaucoma	0.000438	0.00428	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.000435	0.00425	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—TXN—glaucoma	0.000423	0.00414	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000411	0.00401	CbGpPWpGaD
Olopatadine—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000402	0.00393	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CTSA—glaucoma	0.000392	0.00383	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.000392	0.00383	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—LRP12—glaucoma	0.000384	0.00375	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000376	0.00367	CbGpPWpGaD
Olopatadine—S100B—Immune System—CTSA—glaucoma	0.000371	0.00362	CbGpPWpGaD
Olopatadine—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000363	0.00355	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000338	0.00331	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TXNIP—glaucoma	0.00033	0.00322	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—CDKN1B—glaucoma	0.000325	0.00317	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TBK1—glaucoma	0.000324	0.00316	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000322	0.00315	CbGpPWpGaD
Olopatadine—S100B—Immune System—TXNIP—glaucoma	0.000312	0.00305	CbGpPWpGaD
Olopatadine—S100B—Immune System—TBK1—glaucoma	0.000306	0.00299	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—BAD—glaucoma	0.000298	0.00291	CbGpPWpGaD
Olopatadine—S100A12—Immune System—C1QB—glaucoma	0.000293	0.00286	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00029	0.00283	CbGpPWpGaD
Olopatadine—S100B—Immune System—C1QB—glaucoma	0.000277	0.0027	CbGpPWpGaD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000273	0.00267	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—OPN4—glaucoma	0.000266	0.0026	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TXN—glaucoma	0.000261	0.00255	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HEYL—glaucoma	0.000247	0.00242	CbGpPWpGaD
Olopatadine—S100B—Immune System—TXN—glaucoma	0.000247	0.00241	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—OPN4—glaucoma	0.000245	0.0024	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PTGFR—glaucoma	0.00024	0.00234	CbGpPWpGaD
Olopatadine—Cough—Pilocarpine—glaucoma	0.00023	0.000332	CcSEcCtD
Olopatadine—Dizziness—Latanoprost—glaucoma	0.00023	0.000331	CcSEcCtD
Olopatadine—Feeling abnormal—Apraclonidine—glaucoma	0.000229	0.00033	CcSEcCtD
Olopatadine—Dry mouth—Brinzolamide—glaucoma	0.000229	0.000329	CcSEcCtD
Olopatadine—Vomiting—Methazolamide—glaucoma	0.000229	0.000329	CcSEcCtD
Olopatadine—Conjunctivitis—Betaxolol—glaucoma	0.000228	0.000329	CcSEcCtD
Olopatadine—Oedema—Dorzolamide—glaucoma	0.000228	0.000328	CcSEcCtD
Olopatadine—Gastrointestinal pain—Apraclonidine—glaucoma	0.000228	0.000327	CcSEcCtD
Olopatadine—Oedema—Travoprost—glaucoma	0.000227	0.000327	CcSEcCtD
Olopatadine—Rash—Methazolamide—glaucoma	0.000227	0.000326	CcSEcCtD
Olopatadine—Dermatitis—Methazolamide—glaucoma	0.000227	0.000326	CcSEcCtD
Olopatadine—Eye disorder—Clonidine—glaucoma	0.000226	0.000326	CcSEcCtD
Olopatadine—Nausea—Carbachol—glaucoma	0.000226	0.000326	CcSEcCtD
Olopatadine—Infection—Travoprost—glaucoma	0.000226	0.000325	CcSEcCtD
Olopatadine—Headache—Methazolamide—glaucoma	0.000225	0.000324	CcSEcCtD
Olopatadine—Nausea—Levobunolol—glaucoma	0.000223	0.000321	CcSEcCtD
Olopatadine—Infection—Brinzolamide—glaucoma	0.000223	0.000321	CcSEcCtD
Olopatadine—Nervous system disorder—Travoprost—glaucoma	0.000223	0.00032	CcSEcCtD
Olopatadine—Nasopharyngitis—Timolol—glaucoma	0.000223	0.00032	CcSEcCtD
Olopatadine—Discomfort—Pilocarpine—glaucoma	0.000222	0.00032	CcSEcCtD
Olopatadine—Epistaxis—Betaxolol—glaucoma	0.000222	0.000319	CcSEcCtD
Olopatadine—Somnolence—Acetazolamide—glaucoma	0.000221	0.000318	CcSEcCtD
Olopatadine—HRH1—GPCR ligand binding—PTGFR—glaucoma	0.000221	0.00216	CbGpPWpGaD
Olopatadine—Skin disorder—Travoprost—glaucoma	0.000221	0.000317	CcSEcCtD
Olopatadine—Sinusitis—Betaxolol—glaucoma	0.00022	0.000317	CcSEcCtD
Olopatadine—Abdominal pain—Apraclonidine—glaucoma	0.00022	0.000316	CcSEcCtD
Olopatadine—Nervous system disorder—Brinzolamide—glaucoma	0.00022	0.000316	CcSEcCtD
Olopatadine—Rash—Latanoprost—glaucoma	0.000219	0.000316	CcSEcCtD
Olopatadine—Dermatitis—Latanoprost—glaucoma	0.000219	0.000315	CcSEcCtD
Olopatadine—Mediastinal disorder—Clonidine—glaucoma	0.000218	0.000314	CcSEcCtD
Olopatadine—Headache—Latanoprost—glaucoma	0.000218	0.000314	CcSEcCtD
Olopatadine—Skin disorder—Brinzolamide—glaucoma	0.000218	0.000313	CcSEcCtD
Olopatadine—Oedema—Pilocarpine—glaucoma	0.000216	0.00031	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000215	0.000309	CcSEcCtD
Olopatadine—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000215	0.0021	CbGpPWpGaD
Olopatadine—Fatigue—Acetazolamide—glaucoma	0.000215	0.000309	CcSEcCtD
Olopatadine—Infection—Pilocarpine—glaucoma	0.000214	0.000308	CcSEcCtD
Olopatadine—Nausea—Methazolamide—glaucoma	0.000214	0.000307	CcSEcCtD
Olopatadine—Dyspnoea—Brimonidine—glaucoma	0.000213	0.000306	CcSEcCtD
Olopatadine—Somnolence—Brimonidine—glaucoma	0.000212	0.000306	CcSEcCtD
Olopatadine—Rhinitis—Betaxolol—glaucoma	0.000211	0.000304	CcSEcCtD
Olopatadine—Erythema—Clonidine—glaucoma	0.000211	0.000303	CcSEcCtD
Olopatadine—Hypoaesthesia—Betaxolol—glaucoma	0.00021	0.000302	CcSEcCtD
Olopatadine—Pharyngitis—Betaxolol—glaucoma	0.000209	0.000301	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Brimonidine—glaucoma	0.000206	0.000297	CcSEcCtD
Olopatadine—Fatigue—Brimonidine—glaucoma	0.000206	0.000296	CcSEcCtD
Olopatadine—Feeling abnormal—Acetazolamide—glaucoma	0.000205	0.000295	CcSEcCtD
Olopatadine—Hypersensitivity—Apraclonidine—glaucoma	0.000205	0.000295	CcSEcCtD
Olopatadine—Pain—Brimonidine—glaucoma	0.000204	0.000294	CcSEcCtD
Olopatadine—Dyspnoea—Dorzolamide—glaucoma	0.000203	0.000293	CcSEcCtD
Olopatadine—Visual impairment—Betaxolol—glaucoma	0.000203	0.000292	CcSEcCtD
Olopatadine—Somnolence—Dorzolamide—glaucoma	0.000203	0.000292	CcSEcCtD
Olopatadine—Muscle spasms—Clonidine—glaucoma	0.000203	0.000292	CcSEcCtD
Olopatadine—Dyspnoea—Travoprost—glaucoma	0.000203	0.000291	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Timolol—glaucoma	0.0002	0.000288	CcSEcCtD
Olopatadine—Dyspnoea—Brinzolamide—glaucoma	0.0002	0.000288	CcSEcCtD
Olopatadine—Asthenia—Apraclonidine—glaucoma	0.0002	0.000287	CcSEcCtD
Olopatadine—Somnolence—Brinzolamide—glaucoma	0.000199	0.000287	CcSEcCtD
Olopatadine—Vision blurred—Clonidine—glaucoma	0.000199	0.000286	CcSEcCtD
Olopatadine—Eye disorder—Betaxolol—glaucoma	0.000197	0.000284	CcSEcCtD
Olopatadine—Pruritus—Apraclonidine—glaucoma	0.000197	0.000283	CcSEcCtD
Olopatadine—Body temperature increased—Acetazolamide—glaucoma	0.000197	0.000283	CcSEcCtD
Olopatadine—Fatigue—Dorzolamide—glaucoma	0.000197	0.000283	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Travoprost—glaucoma	0.000196	0.000282	CcSEcCtD
Olopatadine—Fatigue—Travoprost—glaucoma	0.000196	0.000282	CcSEcCtD
Olopatadine—Ill-defined disorder—Clonidine—glaucoma	0.000196	0.000282	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—C3—glaucoma	0.000195	0.00191	CbGpPWpGaD
Olopatadine—Pain—Dorzolamide—glaucoma	0.000195	0.000281	CcSEcCtD
Olopatadine—Pain—Travoprost—glaucoma	0.000194	0.000279	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000194	0.000279	CcSEcCtD
Olopatadine—Asthenia—Bimatoprost—glaucoma	0.000194	0.000278	CcSEcCtD
Olopatadine—Fatigue—Brinzolamide—glaucoma	0.000193	0.000278	CcSEcCtD
Olopatadine—Dyspnoea—Pilocarpine—glaucoma	0.000192	0.000276	CcSEcCtD
Olopatadine—Pain—Brinzolamide—glaucoma	0.000192	0.000276	CcSEcCtD
Olopatadine—Somnolence—Pilocarpine—glaucoma	0.000192	0.000276	CcSEcCtD
Olopatadine—Depression—Timolol—glaucoma	0.000191	0.000275	CcSEcCtD
Olopatadine—Pruritus—Bimatoprost—glaucoma	0.000191	0.000275	CcSEcCtD
Olopatadine—Immune system disorder—Betaxolol—glaucoma	0.000191	0.000274	CcSEcCtD
Olopatadine—Diarrhoea—Apraclonidine—glaucoma	0.00019	0.000274	CcSEcCtD
Olopatadine—Malaise—Clonidine—glaucoma	0.00019	0.000274	CcSEcCtD
Olopatadine—Mediastinal disorder—Betaxolol—glaucoma	0.00019	0.000274	CcSEcCtD
Olopatadine—Feeling abnormal—Dorzolamide—glaucoma	0.000188	0.00027	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—RPTOR—glaucoma	0.000188	0.00183	CbGpPWpGaD
Olopatadine—Feeling abnormal—Travoprost—glaucoma	0.000187	0.000269	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—BCL2L1—glaucoma	0.000187	0.00183	CbGpPWpGaD
Olopatadine—Conjunctivitis—Timolol—glaucoma	0.000187	0.000268	CcSEcCtD
Olopatadine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000187	0.000268	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000186	0.000268	CcSEcCtD
Olopatadine—Gastrointestinal pain—Travoprost—glaucoma	0.000186	0.000267	CcSEcCtD
Olopatadine—Feeling abnormal—Brinzolamide—glaucoma	0.000185	0.000266	CcSEcCtD
Olopatadine—S100B—Innate Immune System—C3—glaucoma	0.000185	0.00181	CbGpPWpGaD
Olopatadine—Pain—Pilocarpine—glaucoma	0.000184	0.000265	CcSEcCtD
Olopatadine—Cough—Clonidine—glaucoma	0.000184	0.000265	CcSEcCtD
Olopatadine—Dizziness—Apraclonidine—glaucoma	0.000184	0.000265	CcSEcCtD
Olopatadine—Erythema—Betaxolol—glaucoma	0.000184	0.000264	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—NCK2—glaucoma	0.000182	0.00177	CbGpPWpGaD
Olopatadine—Epistaxis—Timolol—glaucoma	0.000181	0.00026	CcSEcCtD
Olopatadine—Abdominal pain—Dorzolamide—glaucoma	0.00018	0.000259	CcSEcCtD
Olopatadine—Body temperature increased—Dorzolamide—glaucoma	0.00018	0.000259	CcSEcCtD
Olopatadine—Sinusitis—Timolol—glaucoma	0.00018	0.000259	CcSEcCtD
Olopatadine—Dysgeusia—Betaxolol—glaucoma	0.00018	0.000259	CcSEcCtD
Olopatadine—Abdominal pain—Travoprost—glaucoma	0.00018	0.000258	CcSEcCtD
Olopatadine—Asthenia—Acetazolamide—glaucoma	0.000179	0.000257	CcSEcCtD
Olopatadine—Dizziness—Bimatoprost—glaucoma	0.000178	0.000257	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000178	0.000257	CcSEcCtD
Olopatadine—Feeling abnormal—Pilocarpine—glaucoma	0.000178	0.000256	CcSEcCtD
Olopatadine—Discomfort—Clonidine—glaucoma	0.000177	0.000255	CcSEcCtD
Olopatadine—S100B—Innate Immune System—BCL2L1—glaucoma	0.000177	0.00173	CbGpPWpGaD
Olopatadine—Vomiting—Apraclonidine—glaucoma	0.000177	0.000255	CcSEcCtD
Olopatadine—Muscle spasms—Betaxolol—glaucoma	0.000177	0.000254	CcSEcCtD
Olopatadine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000176	0.000254	CcSEcCtD
Olopatadine—Hypersensitivity—Brimonidine—glaucoma	0.000176	0.000253	CcSEcCtD
Olopatadine—Dry mouth—Clonidine—glaucoma	0.000176	0.000253	CcSEcCtD
Olopatadine—Dermatitis—Apraclonidine—glaucoma	0.000175	0.000252	CcSEcCtD
Olopatadine—Headache—Apraclonidine—glaucoma	0.000174	0.000251	CcSEcCtD
Olopatadine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000174	0.0017	CbGpPWpGaD
Olopatadine—Vision blurred—Betaxolol—glaucoma	0.000173	0.000249	CcSEcCtD
Olopatadine—Rhinitis—Timolol—glaucoma	0.000173	0.000249	CcSEcCtD
Olopatadine—Oedema—Clonidine—glaucoma	0.000172	0.000248	CcSEcCtD
Olopatadine—Asthenia—Brimonidine—glaucoma	0.000171	0.000247	CcSEcCtD
Olopatadine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000171	0.00167	CbGpPWpGaD
Olopatadine—Infection—Clonidine—glaucoma	0.000171	0.000246	CcSEcCtD
Olopatadine—Body temperature increased—Pilocarpine—glaucoma	0.00017	0.000245	CcSEcCtD
Olopatadine—Abdominal pain—Pilocarpine—glaucoma	0.00017	0.000245	CcSEcCtD
Olopatadine—Ill-defined disorder—Betaxolol—glaucoma	0.00017	0.000245	CcSEcCtD
Olopatadine—Diarrhoea—Acetazolamide—glaucoma	0.00017	0.000245	CcSEcCtD
Olopatadine—Rash—Bimatoprost—glaucoma	0.00017	0.000245	CcSEcCtD
Olopatadine—Dermatitis—Bimatoprost—glaucoma	0.00017	0.000244	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—BAD—glaucoma	0.00017	0.00166	CbGpPWpGaD
Olopatadine—Pruritus—Brimonidine—glaucoma	0.000169	0.000243	CcSEcCtD
Olopatadine—Headache—Bimatoprost—glaucoma	0.000169	0.000243	CcSEcCtD
Olopatadine—Nervous system disorder—Clonidine—glaucoma	0.000169	0.000243	CcSEcCtD
Olopatadine—Hypersensitivity—Dorzolamide—glaucoma	0.000168	0.000242	CcSEcCtD
Olopatadine—Hypersensitivity—Travoprost—glaucoma	0.000167	0.000241	CcSEcCtD
Olopatadine—Skin disorder—Clonidine—glaucoma	0.000167	0.000241	CcSEcCtD
Olopatadine—Visual impairment—Timolol—glaucoma	0.000166	0.000239	CcSEcCtD
Olopatadine—Malaise—Betaxolol—glaucoma	0.000166	0.000238	CcSEcCtD
Olopatadine—Nausea—Apraclonidine—glaucoma	0.000165	0.000238	CcSEcCtD
Olopatadine—Hypersensitivity—Brinzolamide—glaucoma	0.000165	0.000238	CcSEcCtD
Olopatadine—Dizziness—Acetazolamide—glaucoma	0.000165	0.000237	CcSEcCtD
Olopatadine—Asthenia—Dorzolamide—glaucoma	0.000164	0.000235	CcSEcCtD
Olopatadine—Asthenia—Travoprost—glaucoma	0.000163	0.000234	CcSEcCtD
Olopatadine—Pruritus—Dorzolamide—glaucoma	0.000161	0.000232	CcSEcCtD
Olopatadine—Eye disorder—Timolol—glaucoma	0.000161	0.000232	CcSEcCtD
Olopatadine—Asthenia—Brinzolamide—glaucoma	0.000161	0.000232	CcSEcCtD
Olopatadine—Pruritus—Travoprost—glaucoma	0.000161	0.000231	CcSEcCtD
Olopatadine—S100B—Innate Immune System—BAD—glaucoma	0.00016	0.00157	CbGpPWpGaD
Olopatadine—Cough—Betaxolol—glaucoma	0.00016	0.000231	CcSEcCtD
Olopatadine—Nausea—Bimatoprost—glaucoma	0.00016	0.000231	CcSEcCtD
Olopatadine—Hypersensitivity—Pilocarpine—glaucoma	0.000159	0.000228	CcSEcCtD
Olopatadine—Pruritus—Brinzolamide—glaucoma	0.000159	0.000228	CcSEcCtD
Olopatadine—Vomiting—Acetazolamide—glaucoma	0.000158	0.000228	CcSEcCtD
Olopatadine—Dizziness—Brimonidine—glaucoma	0.000158	0.000227	CcSEcCtD
Olopatadine—Diarrhoea—Dorzolamide—glaucoma	0.000156	0.000225	CcSEcCtD
Olopatadine—Headache—Acetazolamide—glaucoma	0.000156	0.000224	CcSEcCtD
Olopatadine—Immune system disorder—Timolol—glaucoma	0.000156	0.000224	CcSEcCtD
Olopatadine—Diarrhoea—Travoprost—glaucoma	0.000155	0.000224	CcSEcCtD
Olopatadine—Mediastinal disorder—Timolol—glaucoma	0.000155	0.000223	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000155	0.000223	CcSEcCtD
Olopatadine—Asthenia—Pilocarpine—glaucoma	0.000155	0.000223	CcSEcCtD
Olopatadine—Discomfort—Betaxolol—glaucoma	0.000154	0.000222	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—HDAC9—glaucoma	0.000154	0.00151	CbGpPWpGaD
Olopatadine—Dyspnoea—Clonidine—glaucoma	0.000153	0.000221	CcSEcCtD
Olopatadine—Diarrhoea—Brinzolamide—glaucoma	0.000153	0.000221	CcSEcCtD
Olopatadine—Somnolence—Clonidine—glaucoma	0.000153	0.00022	CcSEcCtD
Olopatadine—Dry mouth—Betaxolol—glaucoma	0.000153	0.00022	CcSEcCtD
Olopatadine—Pruritus—Pilocarpine—glaucoma	0.000153	0.000219	CcSEcCtD
Olopatadine—Dizziness—Dorzolamide—glaucoma	0.000151	0.000217	CcSEcCtD
Olopatadine—Rash—Brimonidine—glaucoma	0.000151	0.000217	CcSEcCtD
Olopatadine—Dermatitis—Brimonidine—glaucoma	0.00015	0.000216	CcSEcCtD
Olopatadine—Dizziness—Travoprost—glaucoma	0.00015	0.000216	CcSEcCtD
Olopatadine—Erythema—Timolol—glaucoma	0.00015	0.000216	CcSEcCtD
Olopatadine—Oedema—Betaxolol—glaucoma	0.00015	0.000216	CcSEcCtD
Olopatadine—Headache—Brimonidine—glaucoma	0.00015	0.000215	CcSEcCtD
Olopatadine—Infection—Betaxolol—glaucoma	0.000149	0.000214	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Clonidine—glaucoma	0.000149	0.000214	CcSEcCtD
Olopatadine—Fatigue—Clonidine—glaucoma	0.000148	0.000214	CcSEcCtD
Olopatadine—Dizziness—Brinzolamide—glaucoma	0.000148	0.000213	CcSEcCtD
Olopatadine—Nausea—Acetazolamide—glaucoma	0.000148	0.000213	CcSEcCtD
Olopatadine—Diarrhoea—Pilocarpine—glaucoma	0.000147	0.000212	CcSEcCtD
Olopatadine—Pain—Clonidine—glaucoma	0.000147	0.000212	CcSEcCtD
Olopatadine—Nervous system disorder—Betaxolol—glaucoma	0.000147	0.000211	CcSEcCtD
Olopatadine—Dysgeusia—Timolol—glaucoma	0.000147	0.000211	CcSEcCtD
Olopatadine—Skin disorder—Betaxolol—glaucoma	0.000146	0.000209	CcSEcCtD
Olopatadine—HRH1—G alpha (q) signalling events—EDN1—glaucoma	0.000146	0.00142	CbGpPWpGaD
Olopatadine—Vomiting—Dorzolamide—glaucoma	0.000145	0.000209	CcSEcCtD
Olopatadine—Rash—Dorzolamide—glaucoma	0.000144	0.000207	CcSEcCtD
Olopatadine—Dermatitis—Dorzolamide—glaucoma	0.000144	0.000207	CcSEcCtD
Olopatadine—Rash—Travoprost—glaucoma	0.000143	0.000206	CcSEcCtD
Olopatadine—Dermatitis—Travoprost—glaucoma	0.000143	0.000206	CcSEcCtD
Olopatadine—Headache—Dorzolamide—glaucoma	0.000143	0.000206	CcSEcCtD
Olopatadine—Vomiting—Brinzolamide—glaucoma	0.000143	0.000205	CcSEcCtD
Olopatadine—Dizziness—Pilocarpine—glaucoma	0.000143	0.000205	CcSEcCtD
Olopatadine—Headache—Travoprost—glaucoma	0.000142	0.000205	CcSEcCtD
Olopatadine—Nausea—Brimonidine—glaucoma	0.000142	0.000204	CcSEcCtD
Olopatadine—Feeling abnormal—Clonidine—glaucoma	0.000142	0.000204	CcSEcCtD
Olopatadine—Rash—Brinzolamide—glaucoma	0.000141	0.000203	CcSEcCtD
Olopatadine—Vision blurred—Timolol—glaucoma	0.000141	0.000203	CcSEcCtD
Olopatadine—Dermatitis—Brinzolamide—glaucoma	0.000141	0.000203	CcSEcCtD
Olopatadine—Gastrointestinal pain—Clonidine—glaucoma	0.000141	0.000203	CcSEcCtD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000141	0.00137	CbGpPWpGaD
Olopatadine—Headache—Brinzolamide—glaucoma	0.000141	0.000202	CcSEcCtD
Olopatadine—HRH1—GPCR downstream signaling—OPN4—glaucoma	0.000139	0.00135	CbGpPWpGaD
Olopatadine—Vomiting—Pilocarpine—glaucoma	0.000137	0.000197	CcSEcCtD
Olopatadine—Body temperature increased—Clonidine—glaucoma	0.000136	0.000196	CcSEcCtD
Olopatadine—Abdominal pain—Clonidine—glaucoma	0.000136	0.000196	CcSEcCtD
Olopatadine—Rash—Pilocarpine—glaucoma	0.000136	0.000196	CcSEcCtD
Olopatadine—Dermatitis—Pilocarpine—glaucoma	0.000136	0.000195	CcSEcCtD
Olopatadine—Nausea—Dorzolamide—glaucoma	0.000136	0.000195	CcSEcCtD
Olopatadine—Headache—Pilocarpine—glaucoma	0.000135	0.000194	CcSEcCtD
Olopatadine—Nausea—Travoprost—glaucoma	0.000135	0.000194	CcSEcCtD
Olopatadine—Dyspnoea—Betaxolol—glaucoma	0.000134	0.000192	CcSEcCtD
Olopatadine—Nausea—Brinzolamide—glaucoma	0.000133	0.000192	CcSEcCtD
Olopatadine—Cough—Timolol—glaucoma	0.000131	0.000188	CcSEcCtD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.00013	0.00127	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL1A—glaucoma	0.00013	0.00127	CbGpPWpGaD
Olopatadine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000129	0.000186	CcSEcCtD
Olopatadine—Fatigue—Betaxolol—glaucoma	0.000129	0.000186	CcSEcCtD
Olopatadine—Pain—Betaxolol—glaucoma	0.000128	0.000184	CcSEcCtD
Olopatadine—Nausea—Pilocarpine—glaucoma	0.000128	0.000184	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000127	0.000182	CcSEcCtD
Olopatadine—Hypersensitivity—Clonidine—glaucoma	0.000127	0.000182	CcSEcCtD
Olopatadine—Discomfort—Timolol—glaucoma	0.000126	0.000182	CcSEcCtD
Olopatadine—HRH1—Signaling by GPCR—OPN4—glaucoma	0.000126	0.00123	CbGpPWpGaD
Olopatadine—Dry mouth—Timolol—glaucoma	0.000125	0.00018	CcSEcCtD
Olopatadine—HRH1—GPCR downstream signaling—PTGFR—glaucoma	0.000125	0.00122	CbGpPWpGaD
Olopatadine—Asthenia—Clonidine—glaucoma	0.000124	0.000178	CcSEcCtD
Olopatadine—Feeling abnormal—Betaxolol—glaucoma	0.000124	0.000178	CcSEcCtD
Olopatadine—S100B—Immune System—IL1A—glaucoma	0.000123	0.0012	CbGpPWpGaD
Olopatadine—Oedema—Timolol—glaucoma	0.000122	0.000176	CcSEcCtD
Olopatadine—Pruritus—Clonidine—glaucoma	0.000122	0.000175	CcSEcCtD
Olopatadine—Infection—Timolol—glaucoma	0.000122	0.000175	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—SMO—glaucoma	0.000121	0.00118	CbGpPWpGaD
Olopatadine—Nervous system disorder—Timolol—glaucoma	0.00012	0.000173	CcSEcCtD
Olopatadine—Skin disorder—Timolol—glaucoma	0.000119	0.000171	CcSEcCtD
Olopatadine—Body temperature increased—Betaxolol—glaucoma	0.000118	0.00017	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—CDKN1B—glaucoma	0.000118	0.00115	CbGpPWpGaD
Olopatadine—Diarrhoea—Clonidine—glaucoma	0.000118	0.000169	CcSEcCtD
Olopatadine—Dizziness—Clonidine—glaucoma	0.000114	0.000164	CcSEcCtD
Olopatadine—S100A12—Immune System—C3—glaucoma	0.000114	0.00111	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PTGFR—glaucoma	0.000113	0.00111	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CDKN1B—glaucoma	0.000112	0.00109	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—SMO—glaucoma	0.000111	0.00109	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NTRK2—glaucoma	0.000111	0.00108	CbGpPWpGaD
Olopatadine—Hypersensitivity—Betaxolol—glaucoma	0.00011	0.000159	CcSEcCtD
Olopatadine—Vomiting—Clonidine—glaucoma	0.000109	0.000157	CcSEcCtD
Olopatadine—Dyspnoea—Timolol—glaucoma	0.000109	0.000157	CcSEcCtD
Olopatadine—S100A12—Immune System—BCL2L1—glaucoma	0.000109	0.00106	CbGpPWpGaD
Olopatadine—Somnolence—Timolol—glaucoma	0.000109	0.000157	CcSEcCtD
Olopatadine—Rash—Clonidine—glaucoma	0.000109	0.000156	CcSEcCtD
Olopatadine—Dermatitis—Clonidine—glaucoma	0.000108	0.000156	CcSEcCtD
Olopatadine—Headache—Clonidine—glaucoma	0.000108	0.000155	CcSEcCtD
Olopatadine—S100B—Immune System—C3—glaucoma	0.000108	0.00105	CbGpPWpGaD
Olopatadine—Asthenia—Betaxolol—glaucoma	0.000108	0.000155	CcSEcCtD
Olopatadine—HRH1—Signaling Pathways—LRP12—glaucoma	0.000107	0.00105	CbGpPWpGaD
Olopatadine—Pruritus—Betaxolol—glaucoma	0.000106	0.000153	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Timolol—glaucoma	0.000106	0.000152	CcSEcCtD
Olopatadine—Fatigue—Timolol—glaucoma	0.000106	0.000152	CcSEcCtD
Olopatadine—Pain—Timolol—glaucoma	0.000105	0.000151	CcSEcCtD
Olopatadine—S100B—Immune System—BCL2L1—glaucoma	0.000103	0.00101	CbGpPWpGaD
Olopatadine—Diarrhoea—Betaxolol—glaucoma	0.000103	0.000148	CcSEcCtD
Olopatadine—Nausea—Clonidine—glaucoma	0.000102	0.000147	CcSEcCtD
Olopatadine—Feeling abnormal—Timolol—glaucoma	0.000101	0.000145	CcSEcCtD
Olopatadine—Gastrointestinal pain—Timolol—glaucoma	0.0001	0.000144	CcSEcCtD
Olopatadine—Dizziness—Betaxolol—glaucoma	9.91e-05	0.000143	CcSEcCtD
Olopatadine—S100A12—Immune System—BAD—glaucoma	9.88e-05	0.000965	CbGpPWpGaD
Olopatadine—Body temperature increased—Timolol—glaucoma	9.68e-05	0.000139	CcSEcCtD
Olopatadine—Abdominal pain—Timolol—glaucoma	9.68e-05	0.000139	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	9.64e-05	0.000942	CbGpPWpGaD
Olopatadine—Vomiting—Betaxolol—glaucoma	9.53e-05	0.000137	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—NGFR—glaucoma	9.48e-05	0.000926	CbGpPWpGaD
Olopatadine—Rash—Betaxolol—glaucoma	9.45e-05	0.000136	CcSEcCtD
Olopatadine—Dermatitis—Betaxolol—glaucoma	9.44e-05	0.000136	CcSEcCtD
Olopatadine—Headache—Betaxolol—glaucoma	9.39e-05	0.000135	CcSEcCtD
Olopatadine—CYP3A4—Biological oxidations—GSTT1—glaucoma	9.38e-05	0.000916	CbGpPWpGaD
Olopatadine—S100B—Immune System—BAD—glaucoma	9.34e-05	0.000912	CbGpPWpGaD
Olopatadine—Hypersensitivity—Timolol—glaucoma	9.02e-05	0.00013	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—NTRK1—glaucoma	9.01e-05	0.00088	CbGpPWpGaD
Olopatadine—Nausea—Betaxolol—glaucoma	8.9e-05	0.000128	CcSEcCtD
Olopatadine—Asthenia—Timolol—glaucoma	8.78e-05	0.000126	CcSEcCtD
Olopatadine—Pruritus—Timolol—glaucoma	8.66e-05	0.000125	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	8.42e-05	0.000823	CbGpPWpGaD
Olopatadine—Diarrhoea—Timolol—glaucoma	8.38e-05	0.000121	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—CDKN2B—glaucoma	8.3e-05	0.000811	CbGpPWpGaD
Olopatadine—Dizziness—Timolol—glaucoma	8.1e-05	0.000116	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—EDN1—glaucoma	7.97e-05	0.000778	CbGpPWpGaD
Olopatadine—Vomiting—Timolol—glaucoma	7.78e-05	0.000112	CcSEcCtD
Olopatadine—Rash—Timolol—glaucoma	7.72e-05	0.000111	CcSEcCtD
Olopatadine—Dermatitis—Timolol—glaucoma	7.71e-05	0.000111	CcSEcCtD
Olopatadine—Headache—Timolol—glaucoma	7.67e-05	0.00011	CcSEcCtD
Olopatadine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	7.47e-05	0.00073	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—OPN4—glaucoma	7.43e-05	0.000726	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	7.37e-05	0.00072	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—EDN1—glaucoma	7.34e-05	0.000717	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NGF—glaucoma	7.32e-05	0.000715	CbGpPWpGaD
Olopatadine—Nausea—Timolol—glaucoma	7.27e-05	0.000105	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—C3—glaucoma	6.96e-05	0.00068	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HEYL—glaucoma	6.91e-05	0.000675	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CDKN1B—glaucoma	6.88e-05	0.000672	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTGFR—glaucoma	6.69e-05	0.000654	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NARFL—glaucoma	6.57e-05	0.000642	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CA5A—glaucoma	6.57e-05	0.000642	CbGpPWpGaD
Olopatadine—S100B—Immune System—CDKN1B—glaucoma	6.5e-05	0.000635	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APOE—glaucoma	6.48e-05	0.000633	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CAV1—glaucoma	6.42e-05	0.000627	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—C3—glaucoma	6.41e-05	0.000626	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FN1—glaucoma	6.11e-05	0.000597	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—BAD—glaucoma	6.04e-05	0.00059	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GSTM1—glaucoma	5.97e-05	0.000584	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	5.89e-05	0.000576	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—SMO—glaucoma	5.71e-05	0.000558	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RPTOR—glaucoma	5.24e-05	0.000512	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NCK2—glaucoma	5.07e-05	0.000496	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NOS3—glaucoma	4.85e-05	0.000474	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HDAC9—glaucoma	4.31e-05	0.000421	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CDKN1B—glaucoma	4.2e-05	0.000411	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—EDN1—glaucoma	4.15e-05	0.000405	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MMP9—glaucoma	3.89e-05	0.00038	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—EDN1—glaucoma	3.77e-05	0.000368	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—C3—glaucoma	3.62e-05	0.000354	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—VEGFA—glaucoma	3.5e-05	0.000342	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SMO—glaucoma	3.37e-05	0.00033	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—C3—glaucoma	3.29e-05	0.000321	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CA1—glaucoma	3.21e-05	0.000314	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CTSA—glaucoma	3.11e-05	0.000304	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NTRK2—glaucoma	3.09e-05	0.000302	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CA2—glaucoma	2.94e-05	0.000287	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NGFR—glaucoma	2.65e-05	0.000259	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TP53—glaucoma	2.64e-05	0.000258	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NTRK1—glaucoma	2.52e-05	0.000246	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CDKN2B—glaucoma	2.32e-05	0.000227	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EDN1—glaucoma	2.23e-05	0.000217	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—TXN—glaucoma	2.07e-05	0.000202	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NGF—glaucoma	2.04e-05	0.0002	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—C3—glaucoma	1.94e-05	0.00019	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOE—glaucoma	1.81e-05	0.000177	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CAV1—glaucoma	1.79e-05	0.000175	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FN1—glaucoma	1.71e-05	0.000167	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—BAD—glaucoma	1.69e-05	0.000165	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTT1—glaucoma	1.6e-05	0.000157	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOS3—glaucoma	1.36e-05	0.000132	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ABCA1—glaucoma	1.28e-05	0.000125	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP1B1—glaucoma	1.28e-05	0.000125	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CDKN1B—glaucoma	1.17e-05	0.000115	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MMP9—glaucoma	1.09e-05	0.000106	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTM1—glaucoma	1.02e-05	9.98e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VEGFA—glaucoma	9.77e-06	9.54e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MTHFR—glaucoma	9.03e-06	8.82e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOE—glaucoma	8.41e-06	8.21e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CAV1—glaucoma	8.33e-06	8.14e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TP53—glaucoma	7.38e-06	7.21e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NOS3—glaucoma	6.3e-06	6.15e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGS2—glaucoma	5.76e-06	5.63e-05	CbGpPWpGaD
